Elkhorn Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
|
|||||
|
2025
Q1 | $143K | Buy |
|
|||||
|
2024
Q4 | $150K | Buy |
|
|||||
|
2024
Q3 | $146K | Buy |
|
|||||
|
2024
Q2 | $54K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $11K | Buy |
|
|||||
|
2023
Q2 | $2K | Sell |
|
|||||
|
2023
Q1 | $27K | Sell |
|
|||||
|
2022
Q4 | $55K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $35K | Buy |
|
|||||
|
2021
Q4 | $27K | Buy |
|
|||||
|
2021
Q3 | $14K | Hold |
|
|||||
|
2021
Q2 | $20K | Buy |
|